GlassScriptPhysician profile
David Thorsett
NPI 1558387779
$3,926.69
in general payments reported to CMS, 2019-2025
9 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $820 · 2021: $12.22 · 2022: $128 · 2023: $1,509 · 2024: $1,158 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,232 · Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,232.24 |
| Food and Beverage | $613.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,706.41 | 2019-2024 | Real Intelligence, Journey II, Legion Revision |
| Steelhead Surgical INC | $891.46 | 2020-2024 | |
| Depuy Synthes Sales INC. | $176.47 | 2019-2025 | |
| Abbott Laboratories | $70.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.75 | 2023 | Exparel, Zilretta, Iovera |
| Solventum Corporation | $16.35 | 2025 | Activ.A.C. |
| Heron Therapeutics, INC. | $14.65 | 2025 | Zynrelef |
| Mindray Ds USA, INC. | $14.38 | 2025 | Te7 Max, Te X |
| Kci USA, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thorsett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.